Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin with Irinotecan or Etoposide in Untreated Extensive-Stage Small Cell Lung Cancer
NCT02323737Phase 2Completed
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Jul 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in small cell lung cancer (SCLC), sponsored by Chinese Academy of Medical Sciences. Started Jul 2010; status: completed.
02
Drugs
irinotecan
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT02323737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02323737.